BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22426860)

  • 1. Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection.
    Sun F; Li Y; Jia T; Ling Y; Liang L; Liu G; Chen H; Chen S
    Arch Virol; 2012 Jun; 157(6):1101-11. PubMed ID: 22426860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary neurons become less susceptible to coxsackievirus B5 following maturation: the correlation with the decreased level of CAR expression on cell surface.
    Ahn J; Jee Y; Seo I; Yoon SY; Kim D; Kim YK; Lee H
    J Med Virol; 2008 Mar; 80(3):434-40. PubMed ID: 18205224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
    Liu JY; Wang SM; Chen IC; Yu CK; Liu CC
    Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology.
    Mena I; Fischer C; Gebhard JR; Perry CM; Harkins S; Whitton JL
    Virology; 2000 Jun; 271(2):276-88. PubMed ID: 10860882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
    Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
    Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
    Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
    J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
    Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
    J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor.
    Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK
    Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.
    Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B
    Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
    Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
    Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
    Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
    Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
    Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A
    Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
    Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
    J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor.
    Pinkert S; Westermann D; Wang X; Klingel K; Dörner A; Savvatis K; Grössl T; Krohn S; Tschöpe C; Zeichhardt H; Kotsch K; Weitmann K; Hoffmann W; Schultheiss HP; Spiller OB; Poller W; Fechner H
    Circulation; 2009 Dec; 120(23):2358-66. PubMed ID: 19933937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
    Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
    Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
    Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
    Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
    Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
    J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.